Literature DB >> 16364821

True resistant hypertension: is it possible to be recognized in the office?

Elizabeth Silaid Muxfeldt1, Katia Vergetti Bloch, Armando da Rocha Nogueira, Gil Fernando Salles.   

Abstract

BACKGROUND: True resistant hypertension (RH) is defined as uncontrolled office and ambulatory blood pressure (BP) in spite of an optimal regimen with at least three antihypertensive drugs. The aim of this study is to identify, in the office, clinical, laboratory, electrocardiographic, and echocardiographic variables associated with the occurrence of true RH.
METHODS: These variables were recorded in a cross-sectional study involving 497 resistant hypertensive patients diagnosed by ambulatory BP monitoring as true RH (63.0%) or white coat RH (37.0%). Statistical analysis included bivariate and multivariate logistic regression.
RESULTS: In bivariate analysis, true RH patients were younger, more frequently men, and had significantly higher office BP than white coat RH patients. They also had higher prevalence of physical inactivity, heart failure, and retinopathy, higher fasting glycemia, 24-h proteinuria and albuminuria, and lower serum potassium. In addition, these patients had higher electrocardiographic Sokolow and Cornell voltages and echocardiographic left ventricular mass index and hypertrophy. In multivariate logistic regression the variables best associated with true RH were male sex (P = .026), office systolic BP > or =180 mm Hg (P = .016), fasting glycemia > or =7.0 mmol/L (P = .042), serum potassium <4.5 mmol/L (P = .037), abnormal microalbuminuria (P < .001), adjusted Cornell voltage > or =2.6 mV (P = .002), and echocardiographic left ventricular hypertrophy (P = .009). In an alternative simpler model, proteinuria substituted microalbuminuria and echocardiographic data was excluded. Both predictive models have areas under receiver operating characteristic curve of 0.70.
CONCLUSIONS: True RH can be recognized in the office in selected RH patients. We propose a simple scoring system with these variables that can be used in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364821     DOI: 10.1016/j.amjhyper.2005.06.013

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  31 in total

Review 1.  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?

Authors:  Antonios A Lazaridis; Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

2.  Resistant hypertension: do all definitions describe the same patients?

Authors:  L Boswell; J Pascual; A Oliveras
Journal:  J Hum Hypertens       Date:  2015-01-15       Impact factor: 3.012

Review 3.  Implementing ABPM into Clinical Practice.

Authors:  Alan L Hinderliter; Raven A Voora; Anthony J Viera
Journal:  Curr Hypertens Rep       Date:  2018-02-05       Impact factor: 5.369

4.  White-Coat Effect Is Uncommon in Patients With Refractory Hypertension.

Authors:  Mohammed Siddiqui; Eric K Judd; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2017-07-10       Impact factor: 10.190

Review 5.  Role of ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Guido Grassi; Michele Bombelli; Gino Seravalle; Gianmaria Brambilla; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 6.  [Epidemiology and etiology of therapy-resistant hypertension].

Authors:  C Schirpenbach; M Reincke
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

7.  Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.

Authors:  Hemal Bhatt; Mohammed Siddiqui; Eric Judd; Suzanne Oparil; David Calhoun
Journal:  J Am Soc Hypertens       Date:  2016-03-30

Review 8.  Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

9.  Reserpine Substantially Lowers Blood Pressure in Patients With Refractory Hypertension: A Proof-of-Concept Study.

Authors:  Mohammed Siddiqui; Hemal Bhatt; Eric K Judd; Suzanne Oparil; David A Calhoun
Journal:  Am J Hypertens       Date:  2020-08-04       Impact factor: 2.689

Review 10.  Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.

Authors:  A Oliveras; A de la Sierra
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.